¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2021³â ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãß°èÇмú´ëȸ : 2021-11-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2021³â ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãß°èÇмú´ëȸ : 2021-11-21
±³À°ÀÏÀÚ : 2021-11-21
±³À°Àå¼Ò : ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : 2021³â ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼö¸éÈ£ÈíÇÐȸ  
´ã´çÀÚ : ´ëÇѼö¸éÈ£ÈíÇÐȸ
¿¬¶ôó : 031-787-7420  
À̸ÞÀÏ : sleepbreathing@gmail.com      
±³À°Á¾·ù : À̺ñÀÎÈÄ°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í *»çÀüµî·Ï½Ã Àü¹®ÀÇȸ¿ø : 1¸¸¿ø Àü¹®ÀÇ ºñȸ¿ø : 2¸¸¿ø Àü°øÀÇ ¹× ±âŸ : 1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 08:50~09:00 °³È¸»ç ¹× Àλ縻  ±¸¼ö±Ç (´ëÇѼö¸éÈ£ÈíÇÐȸÀå) 
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 09:00~10:10 Session I. Long-term effects and complications of surgery for obstructive sleep apnea (OSA)  ÀÌÀç¼­ (¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 09:00~09:20 Effects of upper airway surgery on cardiovascular comorbidities and mortality  Á¶¼º¿ì (ºÐ´ç¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 09:20~09:40 Long-term effects and complications of hypoglossal nerve stimulation  ±è»ó¿í (°æ»ó´ëº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 09:40~10:00 Advantages of upper airway surgery superior to PAP therapy  ±èÇöÁ÷ (¼­¿ï´ëº´¿ø) 
Åä·Ð 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 10:00~10:10 Q &A  () 
È޽Ġ11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 10:10~10:30 Coffee Break  () 
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 10:30~11:40 Session II. Home sleep apnea test (HSAT)  ±è¼º¿Ï (°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 10:30~10:50 Recent guidelines for clinical use of a HSAT  ±èÈ¿¿­ (»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 10:50~11:10 HSAT: accuracy vs cost-effectiveness  ±è¿ë¹Î (Ãæ³²´ëº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 11:10~11:30 HSAT AASM scoring rules  ÃÖÁöÈ£ (¼øõÇâ´ëºÎõº´¿ø) 
Åä·Ð 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 11:30~11:40 Q &A  () 
½Ä»ç 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 11:40~12:30 Lunch  () 
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 12:30~13:40 Session III. Pediatric OSA  È«ÀÏÈñ (¼­¿ï¼ö¸éÀÇ¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 12:30~12:50 Phenotypic variance in children with OSA  Ç㼺Àç (°æºÏ´ëº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 12:50~13:10 Pediatric mild OSA: surgical therapy vs non-surgical therapy  ¹è¿ì¿ë (µ¿¾Æ´ëº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 13:10~13:30 PAP therapy in pediatric OSA: critical effects and tips for good adherence  Á¶ÇüÁÖ (½ÅÃ̼¼ºê¶õ½ºº´¿ø) 
Åä·Ð 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 13:30~13:40 Q &A  () 
È޽Ġ11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 13:40~14:00 Coffee Break  () 
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 14:00~14:30 Session IV. Positive airway pressure (PAP): recall issue and referral system  ±¸¼ö±Ç (ºÎ»ê¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 14:00~14:15 PAP recall issue: reasons and harmful effects  ±èµ¿Àº (°è¸í´ëµ¿»êÀÇ·á¿ø) 
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 14:15~14:30 PAP recall issue: safety action and notice  ¹ÚÂù¼ø (°¡Å縯´ë¼ººó¼¾Æ®º´¿ø) 
Åä·Ð 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°­´ç 14:30~15:30 Panel discussion (Referral system for OSA patients with PAP therapy)  ±èÁ¤ÈÆ,À̽ÂÈÆ,Á¶±Ô¼·,¿ÀÀç±¹,Á¤ÀçÈÆ,¹ÚÁ¾·ü(ºÐ´ç¼­¿ï´ëº´¿ø,°í·Á´ë¾È»êº´¿ø,ºÎ»ê´ëº´¿ø,º¸¾Æ½ºÀ̺ñÀÎÈÄ°úÀÇ¿ø,ºÎ»ê¼ûÀ̺ñÀÎÈÄ°úÀÇ¿ø,ÀÌÁö¼ûÀ̺ñÀÎÈÄ°úÀÇ¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2021³â ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãß°èÇмú´ëȸ : 2021-11-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ¿¬¼¼ÀÇ´ë ³»°ú¿¬¼ö°­Á : 2021-11-21
´ÙÀ½±Û (¿Â¶óÀÎ) Á¦71Â÷ ´ëÇÑÅëÁõÇÐȸ ±¹Á¦Çмú´ëȸ : 2021-11-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 10 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 17 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 116 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 25 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 102 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 17 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 11 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 9 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 33 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 7 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 13 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 4 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 11 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 12 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 14 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷